Welcome to Psynova Neurotech

Winners of the Medical Futures Innovations AwardsPsynova Neurotech is exclusively focused on the commercial development and exploitation of novel biomarkers for Neuropsychiatric and other mental illnesses.

 

Building on 12 years of ground-breaking research by its founder Dr Sabine Bahn, Psynova Neurotech is initially concentrating on Schizophrenia and Bipolar Affective Disorder.
 


Media Centre

Mind Games

Dr Sabine Bahn, an expert in neuropsychiatric and neurodevelopmental disorders, is determined to revolutionise the way we diagnose and treat mental illness.

I HAD HEARD THAT SABINE BAHN had a penchant for pink, but it is not until I mention it in the lift on the way to her research centre, and a woman in hot pink leggings says “Can’t you tell I work for her?” that I begin to see that pink is much more than a mere foible. It is a statement of intent.... [read the full article]

 

Latest News

Psynova Neurotech and Rules Based Medicine to co-develop a blood test for the diagnosis of schizophrenia

Cambridge, UK and Austin, TX (June 11 2008): Psynova Neurotech, a UK based company developing novel biomarkers to aid the diagnosis and treatment of neuropsychiatric illnesses, announced today it is partnering with Rules-Based Medicine, Inc. (RBM), the leading multiplexed biomarker testing laboratory, to co-develop and commercialise a blood test for the diagnosis of schizophrenia. [read PDF file]